Back
Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
42
REGN
Regeneron Pharmaceuticals
Last Price:
781.46
Seasonality Move:
14.2%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Regeneron Pharmaceuticals Price Quote
$781.46
-22.87 (-2.84%)
(Updated: November 14, 2024 at 5:55 PM ET)
Regeneron Pharmaceuticals Key Stats
Sell
42
Regeneron Pharmaceuticals (REGN)
is a Sell
Day range:
$803.33 - $823.56
52-week range:
$784.96 - $1,211.20
Dividend yield:
0%
P/E ratio:
23.61
P/S ratio:
6.82
P/B ratio:
3.08%
Volume:
587.9K
Avg. volume:
760.4K
1-year change:
0.96%
Market cap:
$90.2B
Revenue:
$13.1B
EPS:
$40.41
How Much Does Regeneron Pharmaceuticals Make?
-
How Much Are Regeneron Pharmaceuticals's Sales Annually?
REGN Revenues are $13.1B -
How Much Profit Does Regeneron Pharmaceuticals's Make A Year?
REGN net income is $4B
Is Regeneron Pharmaceuticals Growing As A Company?
-
What Is Regeneron Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.11% -
What Is Regeneron Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.3%
Regeneron Pharmaceuticals Stock Price Performance
-
Did Regeneron Pharmaceuticals Stock Go Up Last Month?
Regeneron Pharmaceuticals share price went down by -20.81% last month -
Did REGN's Share Price Rise Over The Last Year?
REGN share price rose by 0.96% over the past 1 year
What Is Regeneron Pharmaceuticals 52-Week High & Low?
-
What Is Regeneron Pharmaceuticals’s 52-Week High Share Price?
Regeneron Pharmaceuticals has traded as high as $1,211.20 over the past 52 weeks -
What Is Regeneron Pharmaceuticals’s 52-Week Low Share Price?
Regeneron Pharmaceuticals has traded as low as $784.96 over the past 52 weeks
Regeneron Pharmaceuticals Price To Free Cash Flow
-
Is Regeneron Pharmaceuticals Stock Overvalued?
Regeneron Pharmaceuticals is trading at a price to free cash flow ratio of 28.47 -
Is Regeneron Pharmaceuticals Stock Undervalued?
Regeneron Pharmaceuticals EV to Free Cash Flow ratio is 24.83 -
What Is Regeneron Pharmaceuticals’s Price Earnings Growth Ratio?
REGN PEG ratio is 1.33 -
Is Regeneron Pharmaceuticals Trading At A Premium To Earnings?
Regeneron Pharmaceuticals EV to EBIT ratio is 16.38
Is It Risky To Buy Regeneron Pharmaceuticals?
-
How Much Debt Does Regeneron Pharmaceuticals Have?
Total long term debt quarterly is $2B -
How Much Cash Does Regeneron Pharmaceuticals Have?
Cash and short term investments quarterly total is $9.8B -
What Is Regeneron Pharmaceuticals’s Book Value Per Share?
Book value per share is 266.32
Is Regeneron Pharmaceuticals Cash Flow Positive?
-
What Is REGN Cash Flow From Operations?
Cash flow from operations (TTM) is $4.2B -
What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.5B -
What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.9B
Regeneron Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
REGN return on invested capital is 16.02% -
What Is Regeneron Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 13.44% -
What Is REGN Return On Equity?
ROE is a measure of profitability and is 17.19%
Regeneron Pharmaceuticals Earnings Date & Stock Price
-
What Is Regeneron Pharmaceuticals's Stock Price Today?
A single share of REGN can be purchased today for 804.33 -
What Is Regeneron Pharmaceuticals’s Stock Symbol?
Regeneron Pharmaceuticals trades on the S&P500 under the ticker symbol: REGN -
When Is Regeneron Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Regeneron Pharmaceuticals is scheduled on January 31, 2025 -
When Is REGN's next ex-dividend date?
Regeneron Pharmaceuticals's next ex-dividend date is November 15, 2024 -
How To Buy Regeneron Pharmaceuticals Stock?
You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Regeneron Pharmaceuticals Competitors
-
Who Are Regeneron Pharmaceuticals's Competitors?
Below is a list of companies who compete with Regeneron Pharmaceuticals or are related in some way:
Regeneron Pharmaceuticals Dividend Yield
-
What Is REGN Dividend Yield?
Regeneron Pharmaceuticals’s dividend yield currently is 0% -
What Is Regeneron Pharmaceuticals’s Payout Ratio?
Regeneron Pharmaceuticals’s payout ratio is 0% -
When Did Regeneron Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Regeneron Pharmaceuticals’s Dividend Per Share?
Regeneron Pharmaceuticals pays a dividend of $0.00 per share
Regeneron Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 29.81% | 6.38% |
| Revenue: | 10.65% | 1.47% |
Analyst Recommendations
| Buy Recommendations: | 10 |
|---|---|
| Hold Recommendations: | 6 |
| Sell Recommendations: | 0 |
| Price Target: | 1,089.43 |
| Upside from Last Price: | 35.45% |